EP Patent

EP3221291A4 — Methods of manufacturing treprostinil and treprostinil derivative prodrugs

Assigned to Insmed Inc · Expires 2018-06-27 · 8y expired

What this patent protects

Patent listed against treprostinil-diolamine.

Drugs covered by this patent

treprostinil-diolamine (TREPROSTINIL DIOLAMINE)

Patent Metadata

Patent number: EP3221291A4
Jurisdiction: EP
Classification: —
Expires: 2018-06-27
Drug substance claim: No
Drug product claim: No
Assignee: Insmed Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.